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a b s t r a c t
Background: The transcription factor signal transducer and activator of transcription 3 (Stat3)
is constitutively activated in many human cancers. It promotes tumor cell proliferation,
inhibits apoptosis, induces angiogenesis and metastasis, and suppresses antitumor host
immune responses. Therefore, Stat3 has emerged as a promisingmolecular target for cancer
therapies. In this study, we evaluated the Stat3-suppressive activity of 38 herbal medicines
traditionally used in Korea.
Methods: Medicinal herb extracts in 70% ethanol were screened for their ability to suppress
Stat3 in the A549 human lung cancer cell line. A Stat3-responsive reporter assay systemwas
used to detect intracellular Stat3 activity in extract-treated cells, and Western blot analyses
were performed to measure the expression proﬁles of Stat3-regulated proteins.
Results: Fifty percent of the 38 extracts possessed at least mild Stat3-suppressive activities
(i.e., activity less than 75% of the vehicle control). Ethanol extracts of Bupleurum falcatum
L., Taraxacum ofﬁcinale Weber, Solanum nigrum L., Ulmus macrocarpa Hance, Euonymus alatus
Sieb.,Artemisia capillaris Thunb., and Saururus chinensis (Lour.) Baill inhibited up to 75% of the
vehicle control Stat3 activity level. A549 cells treated with these extracts also had reduced
Bcl-xL, Survivin, c-Myc, and Mcl-1 expression.
Conclusion: Many medicinal herbs traditionally used in Korea contain Stat3 activity-suppressing substances. Because of the therapeutic impact of Stat3 inhibition, these results
could be useful when developing novel cancer therapeutics from medicinal herbs.
© 2013 Korea Institute of Oriental Medicine. Published by Elsevier. This is an open access. Introduction
he signal transducer and activator of transcription
STAT) proteins comprise a family of seven closely related
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transcription factors with major roles in cytokine signaling.
Of these proteins, Stat3 is well recognized in the ﬁeld of
cancer research because persistent Stat3 activation occurs in
a variety of human cancer cell lines and in primary tumors
vier. This is an open access article under the CC BY-NC-ND license
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Table 1 – List of medicinal plants and parts used in the
study.
Scientiﬁc name Parts used
Acanthopanax sessiliﬂorum Seeman root, bark
Achyranthes japonica Nakai root
Alisma orientale Juzepzuk rhizome
Artemisia capillaris aerial part
Astragalus membranaceus Bunge root
Bupleurum falcatum L. root
Carpesium abrotanoides aerial part
Citrus unshiu Markovich fruit skin
Coix lacryma-jobi L. var. ma-yuen Stapf seed
Cornus ofﬁcinalis Sieb. et Zucc. fruit
Cudrania tricuspidata (Carr.) Bureau ex Lavallee root
Cynanchum wilfordii (Maxim.) Hemsl. rhizome
Dianthus chinensis L. aerial part
Dioscorea batatas Decaisne rhizome
Duchesnea indica (Andr.) Focke whole
Euonymus alatus Sieb. stem cork
Houttuynia cordata Thunb. aerial part
Laminaria japonica leaf
Liriope platyphylla Wang et Tang root
Lithospermum erythrorhizon Sieb. et Zucc. root
Orostachys japonicus A. Berger whole
Panax ginseng C. A. Mey. root
Patrinia scabiosaefolia Fisch. ex Trevir root
Petasites japonicus (Sieb. et Zucc.) Maxim. root
Saururus chinensis (Lour.) Baill aerial part
Schisandra chinensis Baillon fruit
Scutellaria baicalensis Georgi root
Selaginella tamariscina Spring whole
Smilax china L. rhizome
Solanum nigrum L. whole
Sophora ﬂavescens Sol. ex Ait. root
Taraxacum ofﬁcinale Weber whole
Torreya nucifera Sieb. et Zucc. fruit
Ulmus macrocarpa Hance bark
Vitex rotundifolia fruit
Zanthoxylum schinifolium Siebold et Zuccarini fruit
Zingiber ofﬁcinale Roscoe rhizome68
(e.g., lymphoid/myeloid malignancies and solid tumors)2 and
in cells transformed with c-Abl and v-Src oncogenes.3 Many
genetic studies have suggested that the inhibition of this
oncogenic transcriptional regulator could provide an effective
treatment opportunity.
Stat3 is activated through tyrosine phosphorylation, which
is mediated by members of the Jak tyrosine kinase family
in response to numerous growth factors such as epidermal
growth factor (EGF), interleukin-6 (IL-6),4 and other cytokines.5
These growth factors are closely related to tumorigenesis
and cancer progression. In particular, EGF signaling has been
linked to nearly 30% of tumor proliferation events, partly
through Stat3 activation. Hence, Stat3 is a major mediator of
tumorigenesis, especially because it affects many parameters
of malignancy development and progression such as cell pro-
liferation, apoptosis inhibition, and angiogenesis. Examples
of Stat3-regulated genes include c-myc6 and cyclin D17 (which
mediate cell proliferation); Mcl-1, c-IAP2, Bcl-2,8 and Survivin9
(which suppress apoptosis); and matrix metalloproteinase-9
(MMP-9)10 (which mediates cellular invasion).
In addition to regulating genes essential for tumor cell
survival and proliferation, Stat3 also mediates immune
suppression by inhibiting the expression of proinﬂamma-
tory cytokines and chemokines necessary for dendritic cell
activation, by negatively regulating T helper-1 cell-mediated
inﬂammation,11 and by regulating vascular endothelial
growth factor (VEGF) and IL-10-mediated crosstalk between
tumor cells,12 thereby resulting in immune evasion by cancer
cells.
Stat3 plays a critical role in tumorigenesis, inﬂamma-
tion, and crosstalk between tumor and normal cells within
the tumor microenvironment. Thus, Stat3 inhibitors could
be potentially useful for cancer prevention and treatment.5
Numerous studies have been conducted to develop a safe
and efﬁcient strategy of suppressing Stat3 activity in can-
cers. One of the best-known Stat3 inhibitors is AG490, which
inhibits Jak2, the activation partner of Stat3.13 Some small
peptides,14,15 oligonucleotides,16 and small molecules17,18
have anti-Stat3 activity. Several plant-derived polyphenols
such as curcumin,19 resveratrol,20 and magnolol21 also have
Stat3 inhibitory properties.
In our study,we demonstrated that elevated Stat3 signaling
is a common feature of human lung cancer cell lines, and we
evaluated the Stat3 inhibitory activities of 38 ethanol extracts
of plants that have been traditionally used in Korea. These
data could be helpful to the development of novel cancer
chemotherapeutic reagents for lung cancers from naturally
available and conﬁrmed safe medicinal herbs.
2. Methods
2.1. Herbal materials
Table 1 lists the medicinal herbs and parts used in this study.
Each herbal material was selected based on its traditional
use for cancer-like symptoms and/or symptoms that accom-
pany various types of cancers. Each was purchased from one
of three sources: Kwangmyungdang Medicinal Herbs (Ulsan,
Korea), Omniherb (Daegu, Korea), or UKHERB (Busan, Korea).Zizyphus jujuba var. inermis Rehder fruit
The identiﬁcation of eachmedicinal herbwas conﬁrmed by Dr
Go Ya Choi of the Herbal Medicine Resources Group (Daejeon,
South Korea). Voucher specimens were deposited with the
Cancer Research Team of the KM-based Herbal Drug Devel-
opment Group of the Herbal Medicine Research Division at
the Korea Institute of Oriental Medicine (Daejeon, Republic of
Korea). All herbal materials used in this study were grown and
processed in Korea.
2.2. Preparation of ethanol extracts
The dried and ground plantmaterialswere extractedwith 70%
ethanol (100 g/L) by sonication twice each for 1 hour. After
extraction, each extract was ﬁltered through 3 MM paper and
concentrated in vacuo to obtain a dried extract. Each powdered
herbal extractwasﬁrst dissolved indimethyl sulfoxide (DMSO)
at a concentration of 20mg/mL, and thendiluted to 2mg/mL in
phosphate buffered saline (PBS; DMSO concentrations in the
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.3. Cell cultures
uman lung cancer cell lines (A549 and NCI-H23), human col-
rectal cancer cell lines [KM12(SM) and HCT116], human renal
ancer cell lines (Caki-1 and ACHN), human primary lung
ell lines (MRC9 and IMR90), and human normal colon cell
ines (CCD-112CoN) were purchased from the American Type
ulture Collection (ATCC; Manassas, VA. USA). The human
tomach cancer cell lines SNU1 and SNU638 were obtained
rom the Korean Cell Line Bank (Seoul, Korea). The cell lines
549, NCI-H23, SNU1, and SNU638 were cultured in Roswell
ark Memorial Institute (RPMI) medium (Invitrogen, Carlsbad,
A, USA). The cell lines MRC9, IMR90, CCD-112CoN, KM12
SM), and ACHN were cultured in DMEM medium (Invitrogen).
he cell lines Caki-1 and HCT116 were grown in McCoy’s
A medium (Invitrogen). Each medium was supplemented
ith 10% heat-inactivated fetal bovine serum (Invitrogen),
00 U/mL of penicillin, and 100g/mL of streptomycin (Invit-
ogen). The cells were cultured in a humidiﬁed atmosphere
ith 5% CO2 at 37 ◦C.
.4. In vitro Stat3 activity assay
Cignal Stat3 reporter kit (SABiosciences, Valencia, CA, USA)
as used to measure the in vitro Stat3 activity of the A549
ells that had been treated with various herbal extracts. The
ells were plated onto 96-well ﬂat-bottom microwell plates at
density of 1×104 cells/well and cultured for 16–24hours.
hey were then transfected with a Stat3-responsive luciferase
r with a control (positive or negative) construct in accor-
ance with the manufacturer’s instructions. After 24hours,
he cells were treated either with 100g/mL of herbal extract
r with 50Mof AG490 (Sigma, St. Louis, MO, USA) for 16hours
nd lysed for the luciferase assay. Stat3 activity, as measured
y Stat3-responsive construct luciferase activity in herbal
xtract-treated A549 cell lines, was determined with the Dual
uciferase Reporter Assay System (Promega, Madison, WI,
SA). Luciferase activities were measured on a GloMax 20/20
uminometer (Promega).
.5. Western blot analysis
hanges in intracellular protein levels in response to Stat3-
egulating herbal extract treatments were determined by
estern blot analysis. A549 human lung cancer cells were
lated in 60-mm culture dishes at a density of 1×106
ells/dish 16–24hours prior to drug treatment. The cells were
reatedwith 100g/mL of each herbal extract for 24hours. The
otal protein was extracted with an ice-cold radioimmuno-
recipitation assay (RIPA) buffer (Thermo Scientiﬁc, Rockford,
L, USA) that contained CompleteTM Protease Inhibitor Cock-
ail (Roche, Mannheim, Germany) and phosphatase inhibitor
ocktails 2 and 3 (Sigma). The protein concentrations were
uantiﬁed on the basis of the BCA colorimetric method
Thermo Scientiﬁc). For the next step, 25g of the proteins
ere separated by sodium dodecyl sulfate-polyacrylamide gel
lectrophoresis (SDS-PAGE) and transferred to nitrocellulose
embranes. The protein-blotted membranes were blocked
ith a 5% (w/v) skim milk solution in Tris-buffered saline
TBS) with 0.1% Tween 20 for 1 hour at room tempera-
ure (RT). They were then probed with primary antibodies69
at 4 ◦C overnight. The primary antibodies were detected
with species-speciﬁc horseradish peroxidase-conjugated sec-
ondary antibodies for 1 hour at RT. The membranes were
visualized with the SuperSignal West Femto Kit (Thermo Sci-
entiﬁc), and chemiluminescence was detected on a FUSION
SL (Vilber Lourmat, Torcy, France). Primary antibodies against
Bcl-xL,Mcl-1, and Survivinwere purchased fromCell Signaling
Technology (Danvers, MA, USA). Antibodies against phospho-
Jak2, phospho-Stat3 (Y705), and Stat3 were obtained from
Thermo Scientiﬁc. Anti-actin antibody was obtained from
Santa Cruz Biotechnology (Santa Cruz, CA, USA).
3. Results
3.1. Elevated basal Stat3 activity levels in human lung
and kidney cancer cell lines
Stat3 was previously reported to be constitutively active
in many biological tumors, including lung cancer.3 To test
whether basal Stat3 signaling was elevated in various cancer
cell lines in comparison to normal cells, eight human cancer
cell lines from four different tissue origins (e.g., lung, colon,
kidney, and stomach) and three humanprimary cell lines from
lung and colon origins were selected for a comparison of Stat3
activation levels. Each cell line was transfected either with a
Stat3-responsive luciferase construct or a noninducible nega-
tive control construct. The intracellular luciferase activity was
measured 24hours after transfection. The relative Stat3 activ-
ity was calculated by the fold increase in luciferase activity in
the cells transfected with the Stat3-responsive element over
the negative control. As Fig. 1A shows, all human lung cancer
cell lines (i.e., A549 and NCI-H23) and renal cancer cell lines
Caki-1 and ACHN showed elevated basal Stat3 activity levels
(p<0.03), compared to normal cell lines. By contrast, the can-
cer cell lines derived from the colon (KM12 and HCT116) and
from the stomach (SNU1 and SNU638) did not show increased
basal Stat3 activity levels in vitro. Of these cell lines, the human
renal carcinoma cell line Caki-1 and the human lung cancer
cell line A549 exhibited the highest basal Stat3 activity levels,
which were approximately 7–12-fold higher than the negative
control promoter activity. Even though both renal cancer cell
lines that we tested showed highly elevated basal Stat3 levels,
the lack of a normal counterpart prevented us from further
investigating Stat3 signaling in these cell lines. Lung cancer
cell lines also exhibited elevated basal Stat3 activity in com-
parison to normal lung cell lines; therefore, by using actin
as an internal control, we further conﬁrmed the overall Stat3
signaling activity levels among the lung cell lines by evaluating
the expression levels of key proteins that are transcriptionally
regulated by Stat3 (Fig. 1B). All cancer cell lines expressed high
levels of Bcl-xL, c-Myc,Mcl-1, and Survivin, but had lower actin
expressions in comparison to the normal cell lines. This indi-
cates that hyperactive Stat3 signaling is a common feature in
human lung cancer cell lines.
3.2. Screening of herbal extracts for Stat3 inhibitory
properties
We next used a Stat3-responsive reporter assay system to
screen the 38 herbal extracts for their ability to suppress Stat3
70 Integr Med Res ( 2 0 1 4 ) 67–73
Fig. 1 – Intracellular Stat3 activity levels in human lung cell lines. (A) Relative Stat3 activity levels in various primary and
cancer cell lines. The data are representative of one of three independent experiments that were performed in triplicate. (B)
The expression levels of Stat3-regulated proteins in human lung cell lines. *p<0.03.
Table 2 – Effect of herbal medicine ethanol extracts on STAT3 activity.
Scientiﬁc name Parts used STAT3 activity (% of control) * Category
Acanthopanax sessiliﬂorum Seeman root, bark 67.34 ± 6.80 I
Achyranthes japonica Nakai root 70.19 ± 2.99 I
Alisma orientale Juzepzuk root tuber 76.64 ± 3.56 N
Artemisia capillaris Thunb. aerial part 44.35 ± 1.10 I
Astragalus membranaceus Bunge root 82.45 ± 2.28 N
Bupleurum falcatum L. root 31.63 ± 4.04 I
Carpesium abrotanoides L. aerial part 89.84 ± 9.95 N
Citrus unshiu Markovich fruit skin 92.92 ± 4.05 N
Coix lacryma-jobi L. var. ma-yuen Stapf seed 81.09 ± 14.47 N
Cornus ofﬁcinalis Sieb. et Zucc. fruit 67.12 ± 8.75 I
Cudrania tricuspidata (Carr.) Bureau ex Lavallee root 122.44 ± 5.43 N
Cynanchum wilfordii (Maxim.) Hemsl. root tuber 80.53 ± 4.26 N
Dianthus chinensis L. aerial part 53.03 ± 3.16 I
Dioscorea batatas Decaisne root tuber 92.49 ± 2.62 N
Duchesnea indica (Andr.) Focke whole 58.55 ± 9.18 I
Euonymus alatus Sieb. stem cork 43.86 ± 6.68 I
Houttuynia cordata Thunb aerial part 63.93 ± 6.01 I
Laminaria japonica leaf 98.30 ± 18.22 N
Liriope platyphylla Wang et Tang root 75.08 ± 22.21 N
Lithospermum erythrorhizon Sieb. et Zucc. root 76.50 ± 13.66 N
Orostachys japonicus A. Berger whole 63.33 ± 2.94 I
Panax ginseng C. A. Mey. root 75.51 ± 6.86 N
Patrinia scabiosaefolia Fisch. ex Link root 110.27 ± 1.42 N
Petasites japonicus (Sieb. et Zucc.) Maxim. root 81.78 ± 8.43 N
Saururus chinensis (Lour.) Baill aerial part 45.86 ± 6.63 I
Schisandra chinensis Baillon fruit 69.84 ± 3.72 I
Scutellaria baicalensis Georgi root 163.39 ± 13.84 S
Selaginella tamariscina Spring whole 74.18 ± 4.26 I
Smilax china L. root tuber 120.80 ± 24.92 N
Solanum nigrum L. whole 33.83 ± 1.36 I
Sophora ﬂavescens Sol. ex Ait. root 117.30 ± 11.48 N
Taraxacum ofﬁcinale Weber whole 33.79 ± 5.02 I
Torreya nuncifera Sieb. et Zucc. fruit 56.23 ± 8.93 I
Ulmus macrocarpa Hance bark 39.56 ± 6.38 I
Vitex rotundifolia fruit 79.10 ± 5.88 N
Zanthoxylum schinifolium Siebold et Zuccarini fruit 60.33 ± 15.39 I
Zingiber ofﬁcinale Roscoe root tuber 97.81 ± 5.58 N
Zizyphus jujuba var. inermis Rehder fruit 81.59 ± 11.81 N
AG490 (Stat3 inhibitor) – 52.72 ± 5.38
* Mean±S.D. of one representative experiment performed in triplicate (out of three independent experiments).
I, inhibitory (< 75%); N, no effect (between 75% and 125%); S = stimulatory (> 125%).
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Fig. 2 – The expression of Stat3 and related proteins in
Stat3-inhibiting Korean medicine (KM) extract-treated A549
human lung cancer cells.
AC, Artemisia capillaris Thunb.; BF, Bupleurum falcatum L.;
EA, Euonymus alatus Sieb; SC, Saururus chinensis (Lour.)




































Stat3 and Jak2 (its activation partner) and showed reducedeber; UM, Ulmus macrocarpa Hance.
ctivity in A549 cells. We selected the A549 cell line from
mong the lung cancer cell lines for this study because of
ts highly elevated intracellular Stat3 activity levels (Fig. 1A).
549 cells were transfected with a Stat3-responsive luciferase
onstruct and subsequently treated with 100g/mL of various
erbal medicine extracts for 16hours, at which point changes
nStat3 activity in the treated cellswere compared to the activ-
ty in the vehicle (0.5% DMSO)-treated cells. AG490 (50M), a
ell-knownStat3 inhibitor,was the positive control. As Table 2
hows, A549 cells treated with AG490 had approximately 50%
asal Stat3 activity, compared to the vehicle control. Most
xtracts exhibited at least mild Stat3-suppressing activity,
hereas only a few extracts exhibited Stat3-activating proper-
ies. The extracts were grouped into three categories based on
heir effect on Stat3 activity, as follows: “I” was speciﬁcally
nhibitory (< 75% of the vehicle control); “N” was no effect
between 75% and 125%); and “S” was stimulatory (> 125%).
ineteen herbal extracts were found to have Stat3-inhibitory
ffects and only one herbal extract, the root of Scutellaria
aicalensis Georgi, exhibited a Stat3-stimulatory effect. Of the
9 herbal extracts that exhibited anti-Stat3 activity, Bupleurum
alcatum L.(BL), Taraxacum ofﬁcinale Weber, Solanum nigrum L.,
lmus macrocarpa Hance, Euonymus alatus Sieb., Artemisia capil-
aris Thunb., and Saururus chinensis (Lour.) Baill inhibited more
han 50% of the Stat3 activity in A549 human lung cancer cells.
.3. Regulation of Stat3 signaling components by
erbal extracts
ecause Stat3 activation is primarily mediated by Jak2,5 the
evels of Jak2 phosphorylation, Stat3 tyrosine 705 phosphory-
ation (a primary activatingphosphorylation site onStat3), and
he expression levels of Stat3were assessed in the cells treated
ith selected strong anti-Stat3herbal extracts. As Fig. 2 shows,
ak2 phosphorylation was effectively inhibited by all seven
xtracts, and Stat3 phosphorylation at Tyr705 was reduced by71
A. capillaris, S. chinensis, T. ofﬁcinale, and S. nigrum treatment.
The Stat3 expression level was interestingly nearly abrogated
in S. nigrum-treated A549 cells, which suggests that an ethanol
extract of S. nigrum can effectively suppress Stat3 gene tran-
scription and/or translation or enhance Stat3 degradation.
As previously mentioned, the expression levels of many
downstream target proteins are regulated by Stat3, including
well-known oncogenes (such as c-Myc) and apoptosis-
inhibitory proteins (such as Survivin and Bcl-xL). Survivin
expression levels were decreased in A549 cells that had been
treated with any of the seven extracts, and c-Myc expression
levels were reduced in response to A. capillaris, U. macrocarpa,
S. chinensis, T. ofﬁcinale, and S. nigrum (Fig. 2). The expression
levels of Bcl-xL, a Bcl-2 familymember that inhibits apoptosis,
were mildly decreased in response to the extracts of A. capil-
laris,U.macrocarpa, S. chinensis,T. ofﬁcinale, and S. nigrum (Fig. 2).
4. Discussion
The major hallmarks of cancer include uncontrolled cell
growth, growth suppressor evasion, cell death inhibition,
angiogenesis induction, activation of invasion and metasta-
sis, and host immunity avoidance.22 Since the introduction
of mechanism-based targeted therapies to treat human
malignancies, many efforts have been made to develop
chemotherapeutic agents that can control each and/or all of
these hallmarks of cancer. In this light, Stat3 is an attractive
novel target for cancer therapies because it can regulate most
of these hallmarks of cancer.23,24
In this study, we ﬁrst demonstrated that the basal Stat3
signaling levels are elevated in some types of human can-
cer cell lines such as lung and kidney cancers (Fig. 1A). The
protein levels of genes regulated by Stat3 (e.g., Bcl-xL, Sur-
vivin, and c-Myc) consequently are much higher in human
lung cancer cell lines than in normal lung cell lines (Fig. 1B).
All of these proteins are important mediators of tumorigene-
sis that can enhance cell growth, inhibit apoptosis, and induce
drug resistance. These ﬁndings, combined with other numer-
ous reports about Stat3 hyperactivity in human cancers,2 led
us to search for Stat3 signaling inhibitors in traditionally used
herbal medicinal materials.
Thus, 38 medicinal herbs grown and processed in Korea
were selected, extracted with 70% ethanol, and evaluated
for their Stat3-inhibiting activities in the A549 human lung
cancer cell line, which has elevated intrinsic Stat3 activity.
All of these medicinal herbs have been traditionally used
for various cancer-like symptoms. Of these 38 medicinal
herbal extracts, 50% (19 extracts) exhibited at least moderate
Stat3-inhibiting activities,whereas only oneextract (Scutellaria
baicalensis Georgi root) exhibited Stat3-stimulating activity
(Table 2). We further selected the seven most potent extracts
to test whether the Stat3-inhibiting activities of these extracts
could suppress the key hallmarks of cancer proteins that are
regulated by Stat3 (Fig. 2). When treated with these extracts,
the A549 cells, as anticipated, showed inhibited activity ofexpression levels of someor all of the Stat3-regulated proteins.
Solanum nigrum L. (SN) has been widely used in Traditional
Chinese Medicine (TCM) as an elemental ingredient of clinical
r72
TCM cancer therapies.25 A water extract of SN leaves was
reportedly induces apoptosis and autophagy and enhances
the cytotoxic activity of various chemotherapeutic agents in
various human cancer cell lines, including colorectal cancer,
prostate cancer, and breast cancer;20,26,27 however, little is
known about themechanism of its action besides the fact that
it contains many plant polyphenols and ﬂavonoids. Our pre-
liminary study indicated that the ethanol extract of SN only
exhibited moderate cytotoxicity in a single lung cancer cell
line, NCI-H23, among the four cell lines we used in this study
(data not shown). This clearly indicated that the mechanism
behind the possible antitumor activity that we observed for
SN is unrelated to its cytotoxic property. As Fig. 2 and Table 2
show, the SN extract has potent Stat3-inhibitory activity. The
Stat3 transcriptional activity was reduced by more than 65%,
and the expression levels of Stat3 and the phosphorylation
of Jak2 were almost completely abolished. Furthermore, the
expression levels of Mcl-1, c-Myc, Bcl-xL, and Survivin were
reduced.
Another medicinal herb that we tested, BF, is a widely
used herbal remedy in Korea, China, and Japan that possesses
antidepressant,28 antioxidative,29 and antiulcerative30 prop-
erties. In our study, an ethanol extract of BF also exhibited a
potent Stat3-inhibitory effect. However, unlike the SN extract,
the BF extract had little effect on the Stat3 expression level and
only mildly inhibited the phosphorylation of Stat3 and Jak2.
The BF extract efﬁciently inhibited Mcl-1 and Survivin expres-
sion, although it had little effect on the expression levels of
c-Myc and Bcl-xL.
U. macrocarpa Hance. (UM)—also called by its common
name, “large-fruited elm”—is known for its antioxidative and
anti-inﬂammatory properties.31,32 In our study, the UMextract
exhibited potent Stat3-inhibitory activity, yet had little effect
on activating the phosphorylation of Stat3 and Jak2. The UM
extract inhibited c-Myc, Survivin, and Bcl-xL expression but
not Mcl-1 expression.
In conclusion, we evaluated the in vitro Stat3-inhibitory
activity levels of 70% ethanol extracts from 38 herbal
medicines. Of these extracts, seven herbal medicinal
plants—including BL., T. ofﬁcinale Weber, S. nigrum L., UM,
E. alatus Sieb., A. capillaris Thunb., and S. chinensis (Lour.)
Baill.—exhibited potent Stat3 inhibition and reduced the
expression of many cancer-related proteins. Stat3 inhibition
is the common feature exhibited by these plant materials;
however, further research into the mechanism of Stat3 sup-
pression should follow because each extract potentiated a
different level of Stat3 downstream target expression. To
our knowledge, this is the ﬁrst report to demonstrate Stat3-
inhibitory activity in plant extracts. These data could be
a valuable source for the development of novel and safe
chemotherapeutic agents from traditional herbal remedies.
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